Voyager Therapeutics, Inc. (VYGR) Balance Sheet Annual - Discounting Cash Flows
VYGR
Voyager Therapeutics, Inc.
VYGR (NASDAQ)
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
Report Filing: 2025-03-11 2023-12-31 2023-03-07 2022-03-08 2021-02-25 2020-03-03 2019-02-26 2018-03-14 2017-03-15 2016-03-17 2014-12-31 2013-12-31
Total Current Assets 276.8 319.7 124.5 136.7 197.8 304.7 162.5 171.8 178.8 195.9 8.36 0.135
Cash and Short Term Investments 266.7 230.9 118.8 132.5 181.1 281.5 155.8 169.1 174.4 224.3 7.04 0.135
Cash & Equivalents 71.37 68.8 98.96 117.4 104.4 86.04 46.86 31.53 36.64 31.31 7.04 0.135
Short Term Investments 195.3 162.1 19.89 15.11 76.7 195.5 108.9 137.5 137.8 163 0 0
Receivables 4.49 84.45 0.639 0.748 8.01 18.7 0.201 0 2.3 0.411 0 0
Inventory 0 0 0 0 0 2.2 5.11 1.85 1.52 -29.24 0 0
Other Current Assets 5.63 4.35 5.01 3.41 8.62 2.23 1.36 0.888 0.541 0.382 1.32 0
Total Assets 393.1 351.3 159.4 193.9 261.6 354.8 177 184.5 189.6 229.5 11.5 0.149
Total Non-Current Assets 116.2 31.6 34.86 57.16 63.81 50.1 14.55 12.69 10.78 33.56 3.14 0.014
Property, Plant and Equipment 47.66 30 33.34 55.38 61.5 46.46 12.77 10.28 7.89 3.23 2.8 0
Goodwill and Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 65.7 0 0 0 0 1.92 0.628 1.1 1.36 30.01 0 0
Deferred Tax Assets 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 2.87 1.59 1.51 1.78 2.32 1.72 1.15 1.3 1.53 0.321 0.335 0.014
Total Current Liabilities 49.79 64.51 72.59 50.98 26.77 76.01 31.67 15.9 13.8 23.93 2.47 3.98
Accounts Payable 4 1.6 2.57 0.574 0.634 4.07 1.04 1.02 0.55 0.612 1.55 0.95
Notes Payable/Short Term Debt 7.23 3.2 2.83 5.57 4.2 3.19 0 0 0 0 0 2.93
Tax Payables 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 24.39 42.88 59.38 33.89 0 47.23 20.85 3.38 6.76 19.59 0 0
Other Current Liabilities 14.17 16.82 7.82 10.95 21.93 21.52 9.79 11.5 6.49 3.73 0.92 0.105
Total Liabilities 93.29 115 100.3 98.8 107.3 255.2 130.6 50.43 53.64 60.38 10.35 3.98
Total Non-Current Liabilities 43.5 50.45 27.75 47.82 80.5 179.2 98.91 34.53 39.84 36.45 7.87 3.88
Total Long Term Debt 36.5 17.09 20.29 38.61 43.41 30.98 0 0 0 0 6.3 0
Deferred Tax Liabilities Non-Current 0 0 0 0 0 -47.23 0 0 0 0 0 0
Deferred Revenue Non-Current 6 32.36 6.45 8.21 0 194.5 113 31.56 41.58 54.98 0 0
Capital Lease Obligations 43.73 20.29 23.13 44.18 47.61 34.17 0 0 0 0 0 0
Other Long Term Liabilities -42.73 -19.29 -22.12 -43.18 -10.52 -33.17 -14.14 2.97 -1.74 -18.53 1.57 3.88
Total Equity 299.8 236.3 59.02 95.06 154.3 99.51 46.45 134.1 135.9 169.1 1.15 -3.83
Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 299.8 236.3 59.02 95.06 154.3 99.51 46.45 134.1 135.9 169.1 1.15 -3.83
Retained Earnings -326.2 -261.2 -393.5 -347.1 -275.9 -312.6 -269.1 -160.7 -90.02 -49.82 -20.83 -3.83
Accumulated Other Earnings -0.407 -0.048 -0.219 -0.138 -0.134 -0.104 -0.133 -0.287 -0.052 -0.251 -21.98 0
Common Stock 0.055 0.044 0.038 0.038 0.037 0.037 0.032 0.032 0.026 0.025 0.001 0
Preferred Stock 0 0 0 0 0 0 0 0 0 229.5 21.98 0
Additional Paid in Capital 626.3 497.5 452.7 442.3 430.3 412.2 315.6 295 226 219.1 0 0
Total Liabilities & Total Equity 393.1 351.3 159.4 193.9 261.6 354.8 177 184.5 189.6 229.5 11.5 0.149
Total Liabilities & Shareholders' Equity 393.1 351.3 159.4 193.9 261.6 354.8 177 184.5 189.6 229.5 11.5 0.149
Total Investments 261 162.1 19.89 15.11 76.7 197.4 109.6 138.6 139.1 193 0 0
Total Debt 43.73 20.29 23.13 44.18 47.61 34.17 0 0 0 0 6.3 2.93
Net Debt -27.64 -48.51 -75.83 -73.25 -56.83 -51.87 -46.86 -31.53 -36.64 -31.31 -0.73 2.79
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program